This article is available to subscribers. Subscribe now. Already have an account? Sign in

Review ArticleDrug TherapyFree Preview

The Pharmacologic Treatment of Depression

List of authors.
  • William Z. Potter, M.D., Ph.D.,
  • Matthew V. Rudorfer, M.D.,
  • and Husseini Manji, M.D.

IN the past 30 years, there have been major changes in the diagnosis and treatment of depression. Moreover, the biochemical theories of depression suggest that subgroups of patients respond to drugs that affect particular neurotransmitters, in a manner analogous to suggested subgroup responses in hypertension.1 Nonetheless, the original tricyclic antidepressant agents are still the drugs of choice for most patients with major depressive disorders.2 , 3 What follows is a review directed to creating a rational basis for selection among the available antidepressant drugs.Diagnosis of DepressionDepression is currently diagnosed according to the 1987 revision of the Diagnostic and Statistical Manual . . .

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

We are indebted to Mrs. Gladys Kehnemui and Mrs. Lillian Dalton for assistance in the preparation of the manuscript.

Author Affiliations

From the Section on Clinical Pharmacology, Experimental Therapeutics Branch, National Institute of Mental Health, Bethesda, Md. Address reprint requests to Dr. Potter at Bldg. 10, Rm. 2D46, NIMH, 9000 Rockville Pike, Bethesda, MD 20892.

Print Subscriber? Activate your online access.